The effect of arginine glutamate on the stability of monoclonal antibodies in solution

Graphical abstract

[1]  K. D. Collins,et al.  Charge density-dependent strength of hydration and biological structure. , 1997, Biophysical journal.

[2]  Lu-Yun Lian,et al.  A simple method for improving protein solubility and long-term stability. , 2004, Journal of the American Chemical Society.

[3]  Karsten Mäder,et al.  Assessment of net charge and protein-protein interactions of different monoclonal antibodies. , 2011, Journal of pharmaceutical sciences.

[4]  P. Bernadó,et al.  Protein tyrosine phosphatase oligomerization studied by a combination of 15N NMR relaxation and 129Xe NMR. Effect of buffer containing arginine and glutamic acid. , 2007, Journal of the American Chemical Society.

[5]  G. Hautbergue,et al.  Increasing the sensitivity of cryoprobe protein NMR experiments by using the sole low-conductivity arginine glutamate salt. , 2008, Journal of magnetic resonance.

[6]  C Russell Middaugh,et al.  Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies. , 2012, Journal of pharmaceutical sciences.

[7]  Kiichi Fukui,et al.  Effects of Ionic Strength and Sugars on the Aggregation Propensity of Monoclonal Antibodies: Influence of Colloidal and Conformational Stabilities , 2013, Pharmaceutical Research.

[8]  Diwakar Shukla,et al.  Arginine and the Hofmeister Series: the role of ion-ion interactions in protein aggregation suppression. , 2011, The journal of physical chemistry. B.

[9]  Christian Bailly,et al.  Strategies and challenges for the next generation of therapeutic antibodies , 2010, Nature Reviews Immunology.

[10]  Ikoni J Ogaji,et al.  Advances in Natural Polymers as Pharmaceutical Excipients , 2012 .

[11]  Mohammed Shameem,et al.  DSF method optimization and its application in predicting protein thermal aggregation kinetics. , 2013, Journal of pharmaceutical sciences.

[12]  S. Apte,et al.  The effect of buffers on protein conformational stability , 2004 .

[13]  J. Chen,et al.  Different effects of L‐arginine on protein refolding: Suppressing aggregates of hydrophobic interaction, not covalent binding , 2008, Biotechnology progress.

[14]  Linda O Narhi,et al.  High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations. , 2011, Journal of pharmaceutical sciences.

[15]  G. Schneider,et al.  Comparison of fluorescence and light scattering based methods to assess formation and stability of protein-protein complexes. , 2011, Journal of structural biology.

[16]  Miquel Pons,et al.  Protein loop compaction and the origin of the effect of arginine and glutamic acid mixtures on solubility, stability and transient oligomerization of proteins , 2011, European Biophysics Journal.

[17]  Ali Aboel Dahab,et al.  Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody. , 2014, Journal of immunological methods.

[18]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[19]  Mohammed Shameem,et al.  Solution pH that minimizes self-association of three monoclonal antibodies is strongly dependent on ionic strength. , 2012, Molecular pharmaceutics.

[20]  C. Pace,et al.  Forces contributing to the conformational stability of proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Diwakar Shukla,et al.  Understanding the synergistic effect of arginine and glutamic acid mixtures on protein solubility. , 2011, The journal of physical chemistry. B.

[22]  Sujata Sharma,et al.  Inhibition of Protein Aggregation: Supramolecular Assemblies of Arginine Hold the Key , 2007, PloS one.

[23]  C. Russell Middaugh,et al.  High-Throughput Biophysical Analysis of Protein Therapeutics to Examine Interrelationships Between Aggregate Formation and Conformational Stability , 2013, The AAPS Journal.

[24]  A. Robinson,et al.  Competing aggregation pathways for monoclonal antibodies , 2014, FEBS letters.

[25]  H. J. de Jong.  The safety of pharmaceutical excipients. , 1999, Therapie.

[26]  Naushad M Khan Ghilzai,et al.  Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems. , 2006 .

[27]  O. Leavy.  Therapeutic antibodies: past, present and future , 2010, Nature Reviews Immunology.

[28]  Louis M. Weiner,et al.  Monoclonal antibodies: versatile platforms for cancer immunotherapy , 2010, Nature Reviews Immunology.

[29]  Patrizia Restani,et al.  The safety of pharmaceutical excipients. , 2003, Farmaco.

[30]  Steven J Shire,et al.  Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. , 2005, Journal of pharmaceutical sciences.

[31]  Martinus A H Capelle,et al.  High-throughput formulation screening of therapeutic proteins. , 2008, Drug discovery today. Technologies.

[32]  Yong Ding,et al.  Protein Aggregation and Bioprocessing of Virus-like Particles , 2010 .

[33]  Kenneth G. C. Smith,et al.  FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications , 2010, Nature Reviews Immunology.

[34]  Satoshi Saitoh,et al.  Thermodynamic and Fluorescence Analyses to Determine Mechanisms of IgG1 Stabilization and Destabilization by Arginine , 2013, Pharmaceutical Research.

[35]  D. Brems,et al.  Self-buffering antibody formulations. , 2008, Journal of pharmaceutical sciences.

[36]  Yi Li,et al.  High throughput formulation screening for global aggregation behaviors of three monoclonal antibodies. , 2011, Journal of pharmaceutical sciences.

[37]  P. Nordlund,et al.  Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination , 2006, Proceedings of the National Academy of Sciences.

[38]  Deborah S. Goldberg,et al.  Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: role of conformational and colloidal stability. , 2011, Journal of pharmaceutical sciences.

[39]  Kouhei Tsumoto,et al.  Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. , 2007, Biophysical chemistry.

[40]  C. Henry,et al.  Second virial coefficient studies of cosolvent-induced protein self-interaction. , 2005, Biophysical journal.

[41]  Andrew C. Chan,et al.  Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.

[42]  Rudolf Podgornik,et al.  Colloidal interactions between monoclonal antibodies in aqueous solutions. , 2012, Journal of colloid and interface science.

[43]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[44]  Bernhardt L Trout,et al.  Protein-associated cation clusters in aqueous arginine solutions and their effects on protein stability and size. , 2013, ACS chemical biology.